JP2021509902A5 - - Google Patents

Info

Publication number
JP2021509902A5
JP2021509902A5 JP2020537217A JP2020537217A JP2021509902A5 JP 2021509902 A5 JP2021509902 A5 JP 2021509902A5 JP 2020537217 A JP2020537217 A JP 2020537217A JP 2020537217 A JP2020537217 A JP 2020537217A JP 2021509902 A5 JP2021509902 A5 JP 2021509902A5
Authority
JP
Japan
Prior art keywords
copper
composition
composition according
containing agent
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020537217A
Other languages
English (en)
Japanese (ja)
Other versions
JP7324208B2 (ja
JP2021509902A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/012501 external-priority patent/WO2019136358A1/en
Publication of JP2021509902A publication Critical patent/JP2021509902A/ja
Publication of JP2021509902A5 publication Critical patent/JP2021509902A5/ja
Priority to JP2023123138A priority Critical patent/JP7655988B2/ja
Application granted granted Critical
Publication of JP7324208B2 publication Critical patent/JP7324208B2/ja
Priority to JP2025046160A priority patent/JP2025111434A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020537217A 2018-01-05 2019-01-07 近視進行の治療 Active JP7324208B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023123138A JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療
JP2025046160A JP2025111434A (ja) 2018-01-05 2025-03-21 近視進行の治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862614230P 2018-01-05 2018-01-05
US62/614,230 2018-01-05
PCT/US2019/012501 WO2019136358A1 (en) 2018-01-05 2019-01-07 Treatment of myopic progression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023123138A Division JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療

Publications (3)

Publication Number Publication Date
JP2021509902A JP2021509902A (ja) 2021-04-08
JP2021509902A5 true JP2021509902A5 (cg-RX-API-DMAC7.html) 2022-01-18
JP7324208B2 JP7324208B2 (ja) 2023-08-09

Family

ID=67143996

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020537217A Active JP7324208B2 (ja) 2018-01-05 2019-01-07 近視進行の治療
JP2023123138A Active JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療
JP2025046160A Pending JP2025111434A (ja) 2018-01-05 2025-03-21 近視進行の治療

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023123138A Active JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療
JP2025046160A Pending JP2025111434A (ja) 2018-01-05 2025-03-21 近視進行の治療

Country Status (8)

Country Link
US (2) US11524032B2 (cg-RX-API-DMAC7.html)
EP (1) EP3735209B1 (cg-RX-API-DMAC7.html)
JP (3) JP7324208B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250109788A (cg-RX-API-DMAC7.html)
CN (1) CN112105320A (cg-RX-API-DMAC7.html)
AU (2) AU2019205774B2 (cg-RX-API-DMAC7.html)
CA (1) CA3087622A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019136358A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2959242T3 (es) * 2016-03-08 2024-02-22 Univ Utah Res Found Agentes de reticulación y métodos asociados
US11524032B2 (en) 2018-01-05 2022-12-13 University Of Utah Research Foundation Treatment of myopic progression
EP3996644A4 (en) * 2019-07-11 2023-07-26 University of Utah Research Foundation MULTI-AGENT OCULAR FORMULATIONS AND METHODS OF TREATMENT
TW202245810A (zh) * 2021-02-01 2022-12-01 美商艾維娜傳送系統公司 散光之治療
TW202302121A (zh) * 2021-02-11 2023-01-16 猶他大學研究基金會 近視之治療
CN115282349A (zh) * 2022-07-05 2022-11-04 复旦大学附属眼耳鼻喉科医院 一种有利于改善孟加拉玫瑰红-绿光角膜胶原交联技术中cct降低的角膜交联试剂
CN115386105B (zh) * 2022-08-26 2024-03-22 昆明理工大学 多重酶活性纳米酶荧光水凝胶的制备方法及应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
JPH04502012A (ja) * 1989-09-27 1992-04-09 モスコフスキ ナウチノ―イススレドバテルスキ インスティテュト グラツィニフ ボレツネイ イメニ ゲルムゴルツァ 進行性近視の治療用組成物
EP1159941A3 (en) * 1991-10-15 2003-09-17 Ista Pharmaceuticals, Inc. Formulations for use in enzyme-orthokeratology
CN1047523C (zh) * 1993-11-23 1999-12-22 华中理工大学 一种防治近视的滴眼液
AU7488898A (en) 1997-05-16 1998-12-08 Corrective Vision, Inc. Improved contact lens
WO1999045869A1 (en) * 1998-03-09 1999-09-16 Ista Pharmaceuticals, Inc. Use of corneal hardening agents in enzyme orthokeratology
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
JP2004535787A (ja) * 2001-04-13 2004-12-02 インサイト・ゲノミックス・インコーポレイテッド 酵素
CN1509172A (zh) 2001-05-25 2004-06-30 ά����ҩ��˾ 哌仑西平眼用凝胶剂
WO2004058289A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
CN1518981A (zh) * 2003-07-23 2004-08-11 复旦大学附属眼耳鼻喉科医院 一种治疗近视的外用滴眼制剂
MXPA03011987A (es) * 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
US20060134226A1 (en) 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
US20060276777A1 (en) * 2005-04-08 2006-12-07 Coroneo Minas T Corneal shaping
US20080014247A1 (en) 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
WO2012161655A1 (en) 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US20140343480A1 (en) * 2013-05-19 2014-11-20 Avedro, Inc. Systems, methods, and compositions for cross-linking
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
KR20170002425A (ko) * 2014-04-09 2017-01-06 우니베르지태트 라이치히 공막의 의학적 치료용 장치
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
BR112017021374A2 (pt) * 2015-04-09 2018-07-03 Laboratori Baldacci S.P.A. ácido pirrolidona carboxílico (pca) para uso oftálmico
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
ES2959242T3 (es) * 2016-03-08 2024-02-22 Univ Utah Res Found Agentes de reticulación y métodos asociados
EP3713530A4 (en) 2017-11-21 2021-08-18 Sydnexis, Inc. OPHTHALMIC COMPOSITION AND DELIVERY DEVICE FOR IT
US11524032B2 (en) * 2018-01-05 2022-12-13 University Of Utah Research Foundation Treatment of myopic progression
EP3996644A4 (en) * 2019-07-11 2023-07-26 University of Utah Research Foundation MULTI-AGENT OCULAR FORMULATIONS AND METHODS OF TREATMENT
TW202245810A (zh) * 2021-02-01 2022-12-01 美商艾維娜傳送系統公司 散光之治療
TW202302121A (zh) * 2021-02-11 2023-01-16 猶他大學研究基金會 近視之治療

Similar Documents

Publication Publication Date Title
CA3045733A1 (en) Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
JP2019524826A5 (cg-RX-API-DMAC7.html)
US12544400B2 (en) Treatment of myopic progression
JP2019532931A (ja) 眼瞼炎の治療に使用するための医薬組成物
EP2323642A1 (en) Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders
JP6014033B2 (ja) 防腐剤無添加ビマトプロストおよびチモロール溶液
CA3010279A1 (en) Compositions for the treatment of presbyopia
JP2019508472A (ja) 老視の処置のための組成物及び方法
AU2016320905B2 (en) Compositions and methods for prevention and treatment of corneal haze and scarring
JP2022541152A5 (cg-RX-API-DMAC7.html)
AU2026201640A1 (en) Multi-agent ocular formulations and treatment methods
EP2598117A2 (en) Preservative free bimatoprost solutions
JP2021534217A5 (cg-RX-API-DMAC7.html)
JP2024508706A5 (cg-RX-API-DMAC7.html)
JP2024504202A (ja) 乱視の治療
RU2019118904A (ru) Распределение в глазу и фармакокинетика композиций лифитеграста
MX2021006642A (es) Compuestos y composiciones para tratamientos oculares.
EP4106751A1 (en) Alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and other ophthalmic purposes
JP2024508706A (ja) 近視の治療
US20240269115A1 (en) Pyrazolone compounds for use in degenerative retinal diseases
TW202317132A (zh) 眼用組合物及/或用於老花眼、瞳孔放大及/或眼部不適管理之方法
WO2024211322A2 (en) Ripasudil based ophthalmic treatments
WO2025049378A1 (en) Netarsudil ophthalmological formulations with less toxicity
JP2023022567A (ja) 洗眼組成物
RU2019107585A (ru) Офтальмологические фармацевтические композиции и их применение